AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

AstraZeneca Ph AstraZeneca Pharma Ltd. | BSE 9338.45 15.45 (0.17%) | NSE 9346.50 31.00 (0.33%) | Trade | Add

BSE Live

Oct 29, 16:01

9338.45 15.45 (0.17%)

Volume

AVERAGE VOLUME

5-Day

349

10-Day

398

30-Day

731

590

Prev. Close

9323.00
Open Price

9394.95

Bid Price (Qty.)
9338.45 (2)
Offer Price (Qty.)
9375.85 (1)

NSE Live

Oct 29, 15:18

9346.50 31.00 (0.33%)

Volume

AVERAGE VOLUME

5-Day

8,496

10-Day

7,603

30-Day

11,888

5,257

Prev. Close

9315.50
Open Price

9359.50

Bid Price (Qty.)
9346.00 (9)
Offer Price (Qty.)
9356.00 (2)

Financials

Print/Copy to Excel : Go

Profit & Loss account of AstraZeneca Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	1,713.29	1,295.53	1,002.97	805.60	813.56
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	1,713.29	1,295.53	1,002.97	805.60	813.56
Total Operating Revenues	1,716.29	1,295.53	1,002.97	805.60	813.56
Other Income	40.63	34.80	26.10	14.76	12.84
Total Revenue	1,756.92	1,330.33	1,029.07	820.36	826.40
EXPENSES
Cost Of Materials Consumed	287.13	129.02	84.38	89.61	97.26
Purchase Of Stock-In Trade	1,008.82	499.31	324.46	207.88	194.74
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-332.94	-33.77	-48.86	14.47	2.95
Employee Benefit Expenses	257.44	241.45	259.10	230.21	219.54
Finance Costs	1.46	1.20	0.63	0.95	1.09
Depreciation And Amortisation Expenses	39.99	14.94	16.26	16.95	20.13
Other Expenses	241.87	275.07	218.77	177.25	163.60
Total Expenses	1,503.77	1,127.22	854.74	737.32	699.31
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	253.15	203.11	174.33	83.04	127.09
Exceptional Items	-96.79	16.43	-40.23	0.00	0.00
Profit/Loss Before Tax	156.36	219.54	134.10	83.04	127.09
Tax Expenses-Continued Operations
Current Tax	60.10	53.55	38.30	22.63	34.83
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-19.92	-0.90	-3.49	-1.19	-1.04
Tax For Earlier Years	0.44	5.38	0.00	0.00	0.00
Total Tax Expenses	40.62	58.03	34.81	21.44	33.79
Profit/Loss After Tax And Before ExtraOrdinary Items	115.74	161.51	99.29	61.60	93.30
Profit/Loss From Continuing Operations	115.74	161.51	99.29	61.60	93.30
Profit/Loss For The Period	115.74	161.51	99.29	61.60	93.30
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	46.30	64.60	39.70	24.60	37.30
Diluted EPS (Rs.)	46.30	64.60	39.70	24.60	37.30
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	60.00	40.00	20.00	5.00	5.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	1,600.00	1,200.00	800.00	500.00	100.00